Study title:
Nucl Med Commun. 1999 Mar;20(3):255-61.
Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of
malignant melanoma: a comparison of ultrasonographic and radiological methods of
diagnosis.
Dietlein M, Krug B, Groth W, Smolarz K, Scheidhauer K, Psaras T, Stützer H,
Lackner K, Schicha H.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|